Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Women with PCOS are more likely to have gum disease.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Young women with PCOS and no other heart risk factors have normal heart function.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

FOXA1 and CCL2 genes are more active in women with PCOS, varying by phenotype.

PCOS shares similar genetic traits across different diagnosis criteria and is linked to other health conditions.

Late onset of first period and irregular development of sexual traits in teenage girls can lead to poorer reproductive health.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

PCOS is viewed as a kapha-related disorder in Ayurveda, involving fat tissue issues and channel blockages.

Obese women with PCOS are more likely to have fatty liver disease.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.